Login
Register
Questions
Unanswered
Tags
Categories
Ask a Question
Search
EconTrack
About EconSpark
Ask a Question
Recent questions tagged prescription-drugs
0
votes
0
answers
69
views
Medicare Drug Price Negotiation Program -- CMS invites comment on initial guidance (by 4/14)
asked
10 days
ago
by
Andrew Reamer
(
41k
points)
medicare
cms
prescription-drugs
0
votes
0
answers
51
views
Medicare Prescription Drug Inflation Rebate Program -- CMS seeks input on initial guidance (by 3/11)
asked
1 month
ago
by
Andrew Reamer
(
41k
points)
cms
medicare
prescription-drugs
0
votes
0
answers
235
views
Dosage/Administration Labeling for Prescription Drugs -- FDA invites comments on draft guidance (by 3/14)
asked
2 months
ago
by
Andrew Reamer
(
41k
points)
fda
prescription-drugs
0
votes
0
answers
142
views
Medicare Advantage (MA) Plans & Prescription Drug Plans (PDP) Bid Pricing Tool -- CMS invites comments to OMB (by 2/13)
asked
2 months
ago
by
Andrew Reamer
(
41k
points)
medicare-advantage
prescription-drugs
cms
bid-pricing-tools
0
votes
0
answers
73
views
Medicare Drug Price Negotiation Program -- CMS Announces Key Y1 Dates (1.11.23)
asked
2 months
ago
by
Andrew Reamer
(
41k
points)
cms
prescription-drugs
0
votes
0
answers
273
views
CMS 2024 Proposed Changes to Medicare Advantage/Medicare Part D Programs--comments invited (by 2/13)
asked
3 months
ago
by
Andrew Reamer
(
41k
points)
cms
medicare-advantage
prescription-drugs
medicare-part-d
0
votes
0
answers
261
views
Prescription Drug Prices 2016-2022 and Spending 2016-2021 -- ASPE reports (9.30.22)
asked
5 months
ago
by
Andrew Reamer
(
41k
points)
hhs
aspe
prescription-drugs
0
votes
0
answers
192
views
Intl Prescription Drug Price Comparisons: Current Empirical Estimates/Comparisons w/ Previous Studies -- ASPE (7.1.22)
asked
8 months
ago
by
Andrew Reamer
(
41k
points)
aspe
prescription-drugs
0
votes
0
answers
902
views
Prescription Drug/Health Care Spending Data Collection (RxDC) -- CMS invites comments to OMB (by 7/28)
asked
8 months
ago
by
Andrew Reamer
(
41k
points)
cms
prescription-drugs
rxdc
0
votes
0
answers
193
views
Prescription Drug Promotion Research -- FDA invites comments on proposed tradeoff analysis (by 6/24)
asked
11 months
ago
by
Andrew Reamer
(
41k
points)
fda
prescription-drugs
0
votes
0
answers
539
views
Impact of PBM Business Practices on Drug Affordability/Access -- FTC requests information (by 5/25)
asked
1 year
ago
by
Andrew Reamer
(
41k
points)
ftc
pbm
prescription-drugs
0
votes
0
answers
281
views
Medicare Advantage and Part D Proposed Rule for 2023 -- CMS invites comments (by 3/7)
asked
1 year
ago
by
Andrew Reamer
(
41k
points)
medicare
medicare-advantage
prescription-drugs
cms
0
votes
0
answers
202
views
Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships -- ASPE issues RAND report (10/14)
asked
1 year
ago
by
Andrew Reamer
(
41k
points)
pharmaceuticals
prescription-drugs
0
votes
0
answers
384
views
Annual Drug/Health Care Spending Data Collection -- CMS/EBSA/IRS/OPM invite comments on interim rule (by 1/24)
asked
1 year
ago
by
Andrew Reamer
(
41k
points)
cms
medicare
prescription-drugs
0
votes
0
answers
452
views
Enhancing Safety/Security of Pharma Distribution Supply Chain -- FDA public mtg (11/16), seeks comments (by 1/18)
asked
1 year
ago
by
Andrew Reamer
(
41k
points)
fda
drug-supply-chain
prescription-drugs
0
votes
0
answers
169
views
Prescription Drug Event (PDE) Data Collection from Part D Providers -- CMS invites comment to OMB (by 10/4)
asked
1 year
ago
by
Andrew Reamer
(
41k
points)
cms
pde
prescription-drugs
0
votes
0
answers
370
views
Prescription Drug Data for Medicare Part D Payments -- CMS invites comments on proposed collection (by 8/23)
asked
1 year
ago
by
Andrew Reamer
(
41k
points)
cms
prescription-drugs
medicare
To see more, click for the
full list of questions
or
popular tags
.
...